A report that the NHS is considering scaling back its recruitment drive and deploying greater use of AI to plug the gap has ...

Underlying many of these challenges is a broader industry mindset that can, at times, slow progress. There is often a ...

Neuroscience isn't currently one of the top strategic R&D priorities at GSK, but a new alliance with ABL Bio adds to the sense that its focus may be shifting. The UK-headquartered pharma group is ...

The WHO has held a closed expert meeting to identify potential vaccines for the Bundibugyo species of Ebola that is causing ...

UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category with $21 billion ...

Fresh from agreeing a wide-ranging alliance with Regeneron worth up to $2.3 billion, Parabilis Medicines has decided to ...

The preliminary agenda has just been released! Returning as the largest and definitive ADC congress, the 17th World ADC San ...

The US Supreme Court has rejected lawsuits from pharma groups challenging Medicare's drug pricing negotiation powers, saying ...

A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major ...

A phase 2 trial of Sanofi's experimental therapy for alpha-1 antitrypsin deficiency (AATD) has raised the hope of an ...

The FDA has approved AstraZeneca's aldosterone synthase inhibitor (ASI) – baxdrostat – for hard-to-treat hypertension, making ...

The turmoil at the FDA continues with the news that Tracy Beth Høeg has been fired as acting head of the FDA's Center for ...